Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report [0.03%]
肝细胞癌合并膜性下腔静脉阻塞引起的毕夏氏综合症一例报告及长期随访
Choong Hee Kim,Gwang Hyeon Choi,Hee Young Na et al.
Choong Hee Kim et al.
Membranous obstruction of the inferior vena cava (MOVC) is a rare subset of Budd-Chiari syndrome (BCS) with a subacute onset that is often complicated by cirrhosis and hepatocellular carcinoma (HCC). Here we report a case of recurrent HCC i...
Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma [0.03%]
介入消融联合免疫治疗肝癌的研究进展与未来方向
Dong-Hyun Kim
Dong-Hyun Kim
Interventional oncology (IO) local therapies of hepatocellular carcinoma (HCC) can activate anti-cancer immunity and it is potentially leading to an anti-cancer immunity throughout the body. For the development of an effective HCC treatment...
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma [0.03%]
液体活检在肝细胞癌早期检测和治疗监测中的应用
Eun-Ji Choi,Young-Joon Kim
Eun-Ji Choi
Advances in our knowledge of the molecular characteristics of hepatocellular carcinoma (HCC) have enabled significant progress in the detection and therapeutic prediction of HCC. As a non-invasive alternative to tissue biopsy, liquid biopsy...
Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report [0.03%]
阿特朱单抗与贝伐珠单抗联合治疗肝细胞癌伴淋巴结转移的病例报告
Sang Youn Hwang,Sun Mi Lee,Jeong Woo Lim et al.
Sang Youn Hwang et al.
Sorafenib is the oldest first line systemic treatment in patients with advanced hepatocellular carcinoma (HCC) and has been used exclusively for nearly 10 years. The superiority of administering a combination of atezolizumab plus bevacizuma...
A case report of a patient presented with skin ulcer after treatment of lenvatinib [0.03%]
仑伐替尼治疗后出现皮肤溃疡的病例报告
Serin Cha,Dong Woo Kim,Jung Wan Choe et al.
Serin Cha et al.
A 60-year-old man diagnosed with unresectable hepatocellular carcinoma (HCC) presented to the hospital with pain in the perineal region. He had been taking lenvatinib every day for 2 months after he was diagnosed with HCC with metastases to...
Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma [0.03%]
根据肝细胞癌的地区疾病特征分析放射治疗应用差异
Chai Hong Rim
Chai Hong Rim
There are differences in opinion regarding the application of external beam radiotherapy in the treatment of hepatocellular carcinoma. Some major guidelines state that external beam radiotherapy is yet to attain a sufficient level of eviden...
Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report [0.03%]
肝癌伴静脉瘤栓及肺转移患者行肺叶切除术后肝移植治疗的个案报告
Dong Jin Joo,Do Young Kim,Jinsil Seong et al.
Dong Jin Joo et al.
Hepatocellular carcinoma (HCC) with distant metastasis is an absolute contraindication for liver transplantation (LT). However, it is still unclear whether LT is feasible or acceptable in such patients, albeit after being treated with a mul...
Ji Won Han,Su-Hyung Park
Ji Won Han
Hepatocellular carcinoma (HCC) is the fifth most common cancer, and the second leading cause of cancer-related death worldwide. Although recent advances in immune checkpoint inhibitor-based immunotherapy have initiated a new era for advance...
Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial [0.03%]
载药微球肝动脉化疗栓塞与射频消融治疗单发小肝癌的疗效比较：一项前瞻性非随机对照研究
Tae Hoon Kim,Na Hye Kim,Jin Dong Kim et al.
Tae Hoon Kim et al.
Background/aims: Surgical resection, transplantation, and radiofrequency ablation (RFA) are generally accepted as amenable treatments for small hepatocellular carcinoma (HCC). Recently drug-eluting beads (DEB) which had s...